MedTrace Logo

Validation of Handheld Ultrasound Devices in Rheumatology

NCT06580886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-08-30

No results posted yet for this study

Summary

The goal of this clinical trial is to test the concurrent validity of the Clarius handheld ultrasound devices versus gold-standard device to detect characteristic features of healthy and rheumatic joints in adults Psoriatic Arthtritis patients (i.e. anatomical structures and vascular flow).

Conditions

Interventions

DEVICE

Ultrasound

All patients having ultrasound with Clarius L15/L20 and GE logic E9/E10 in same visit.

Sponsors & Collaborators

  • University of Florida

    collaborator OTHER

  • University Health Network, Toronto

    collaborator OTHER

  • Novartis

    collaborator INDUSTRY

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Sibel Z Aydin, Prof · Ottawa Hospital Research Institute

  • Lihi Eder, Prof · Women's College Hospital

  • Gurjit Kaeley, Prof · University of Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-16
Primary Completion
2024-06-28
Completion
2024-06-28
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06580886 on ClinicalTrials.gov